Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Last Name

profileMel B. Feany, M.D., Ph.D.

TitleProfessor of Pathology
InstitutionBrigham and Women's Hospital
AddressBrigham and Women's Hospital
Pathology Dept., Room 630
77 Avenue Louis Pasteur
Boston MA 02115
vCardDownload vCard (login for email)

Collapse Mentoring 
Collapse completed student projects
SIRT6: A potential neuroprotective gene against PD pathology
Summer, 06/01/14 - 08/30/14
Dysregulated tyrosine phosphorylation enhances tau-induced neurodegeneration in Drosophila
Summer, 05/26/08 - 09/01/08
Genetic Modifiers of Neurodegeneration in a Drosophilia Model of Alzheimer's Disease
Summer, 07/01/02 - 08/31/02
Screening for Genetic Modifiers of Neurodegeneration in a Drosophila Model of Alzheimer's Disease
Summer, 06/01/01 - 08/30/01
Chromatin Structure in the Aging Brain
Full Time, 04/01/14 - 06/30/14

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
RF1AG057294     (FEANY, MEL B)Sep 30, 2017 - Jun 30, 2022
Peripheral Control of Brain Proteostasis in Aging and Alzheimer Disease
Role: Principal Investigator

R01NS098821     (FEANY, MEL B)Sep 25, 2017 - Jun 30, 2022
Genome Wide Analysis of Alpha-Synuclein Neurotoxicity
Role: Principal Investigator

RF1AG057331     (FEANY, MEL B)Sep 15, 2017 - Jun 30, 2022
Integrative Multi-Omic Discovery of Proximal Mechanisms Driving Age-Dependent Neurodegeneration
Role: Principal Investigator

P01HD076892     (MESSING, ALBEE)Sep 20, 2014 - Jul 31, 2019
Alexander disease: mechanisms, modifiers, and therapeutics
Role: Co-Principal Investigator

R21NS082818     (FEANY, MEL B)Jul 1, 2013 - Jun 30, 2015
Reductive Stress in Complex I Deficiency
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ordonez DG, Lee MK, Feany MB. a-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton. Neuron. 2018 Jan 03; 97(1):108-124.e6. PMID: 29249285.
    View in: PubMed
  2. Bardai FH, Wang L, Mutreja Y, Yenjerla M, Gamblin TC, Feany MB. A Conserved Cytoskeletal Signaling Cascade Mediates Neurotoxicity of FTDP-17 Tau Mutations In Vivo. J Neurosci. 2018 Jan 03; 38(1):108-119. PMID: 29138281.
    View in: PubMed
  3. Collier TJ, Srivastava KR, Justman C, Grammatopoulous T, Hutter-Paier B, Prokesch M, Havas D, Rochet JC, Liu F, Jock K, de Oliveira P, Stirtz GL, Dettmer U, Sortwell CE, Feany MB, Lansbury P, Lapidus L, Paumier KL. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiol Dis. 2017 Oct; 106:191-204. PMID: 28711409.
    View in: PubMed
  4. Etchegaray JI, Elguero EJ, Tran JA, Sinatra V, Feany MB, McCall K. Defective Phagocytic Corpse Processing Results in Neurodegeneration and Can Be Rescued by TORC1 Activation. J Neurosci. 2016 Mar 16; 36(11):3170-83. PMID: 26985028; PMCID: PMC4792933.
  5. Wang L, Hagemann TL, Messing A, Feany MB. An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease. J Neurosci. 2016 Feb 03; 36(5):1445-55. PMID: 26843629; PMCID: PMC4737762.
  6. Frost B, Bardai FH, Feany MB. Lamin Dysfunction Mediates Neurodegeneration in Tauopathies. Curr Biol. 2016 Jan 11; 26(1):129-36. PMID: 26725200; PMCID: PMC4713335 [Available on 01/11/17].
  7. Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL, Wisniewski T, Woulfe JM, Yamada M, Dickson DW. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2016 Jan; 131(1):87-102. PMID: 26659578; PMCID: PMC4879001 [Available on 01/01/17].
  8. Wang L, Hagemann TL, Kalwa H, Michel T, Messing A, Feany MB. Nitric oxide mediates glial-induced neurodegeneration in Alexander disease. Nat Commun. 2015 Nov 26; 6:8966. PMID: 26608817; PMCID: PMC4674772.
  9. Merlo P, Frost B, Peng S, Yang YJ, Park PJ, Feany M. p53 prevents neurodegeneration by regulating synaptic genes. Proc Natl Acad Sci U S A. 2014 Dec 16; 111(50):18055-60. PMID: 25453105; PMCID: PMC4273405.
  10. Frost B, Götz J, Feany MB. Connecting the dots between tau dysfunction and neurodegeneration. Trends Cell Biol. 2015 Jan; 25(1):46-53. PMID: 25172552; PMCID: PMC4275400.
  11. Hegde VR, Vogel R, Feany MB. Glia are critical for the neuropathology of complex I deficiency in Drosophila. Hum Mol Genet. 2014 Sep 01; 23(17):4686-92. PMID: 24760769; PMCID: PMC4119418.
  12. Mannix R, Meehan WP, Feany M, Grant PE, Mandeville J, Kaplan DL, Whalen M. Genetic influences and neuropathological sequelae of repetitive brain injury. Reply. Ann Neurol. 2014 Apr; 75(4):618. PMID: 24242978.
    View in: PubMed
  13. Frost B, Hemberg M, Lewis J, Feany MB. Tau promotes neurodegeneration through global chromatin relaxation. Nat Neurosci. 2014 Mar; 17(3):357-66. PMID: 24464041; PMCID: PMC4012297.
  14. Shulman JM, Imboywa S, Giagtzoglou N, Powers MP, Hu Y, Devenport D, Chipendo P, Chibnik LB, Diamond A, Perrimon N, Brown NH, De Jager PL, Feany MB. Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms. Hum Mol Genet. 2014 Feb 15; 23(4):870-7. PMID: 24067533; PMCID: PMC3900103.
  15. Mannix R, Meehan WP, Mandeville J, Grant PE, Gray T, Berglass J, Zhang J, Bryant J, Rezaie S, Chung JY, Peters NV, Lee C, Tien LW, Kaplan DL, Feany M, Whalen M. Clinical correlates in an experimental model of repetitive mild brain injury. Ann Neurol. 2013 Jul; 74(1):65-75. PMID: 23922306.
    View in: PubMed
  16. DuBoff B, Feany M, Götz J. Why size matters - balancing mitochondrial dynamics in Alzheimer's disease. Trends Neurosci. 2013 Jun; 36(6):325-35. PMID: 23582339.
    View in: PubMed
  17. Hill-Burns EM, Singh N, Ganguly P, Hamza TH, Montimurro J, Kay DM, Yearout D, Sheehan P, Frodey K, McLear JA, Feany MB, Hanes SD, Wolfgang WJ, Zabetian CP, Factor SA, Payami H. A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. Pharmacogenomics J. 2013 Dec; 13(6):530-7. PMID: 23032990; PMCID: PMC3538110.
  18. DuBoff B, Götz J, Feany MB. Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron. 2012 Aug 23; 75(4):618-32. PMID: 22920254; PMCID: PMC3428596.
  19. Ryan EL, DuBoff B, Feany MB, Fridovich-Keil JL. Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia. Dis Model Mech. 2012 Nov; 5(6):796-803. PMID: 22736462; PMCID: PMC3484862.
  20. Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE. Alexander disease. J Neurosci. 2012 Apr 11; 32(15):5017-23. PMID: 22496548; PMCID: PMC3336214.
  21. Khurana V, Merlo P, DuBoff B, Fulga TA, Sharp KA, Campbell SD, Götz J, Feany MB. A neuroprotective role for the DNA damage checkpoint in tauopathy. Aging Cell. 2012 Apr; 11(2):360-2. PMID: 22181010.
    View in: PubMed
  22. Wang L, Colodner KJ, Feany MB. Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model. J Neurosci. 2011 Feb 23; 31(8):2868-77. PMID: 21414908; PMCID: PMC3082397.
  23. Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, Kramer PL, Schneider JA, Bennett DA, Feany MB, De Jager PL. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011 Feb 11; 88(2):232-8. PMID: 21295279; PMCID: PMC3035702.
  24. Shulman JM, De Jager PL, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol. 2011; 6:193-222. PMID: 21034221.
    View in: PubMed
  25. Colodner KJ, Feany MB. Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy. J Neurosci. 2010 Dec 01; 30(48):16102-13. PMID: 21123557; PMCID: PMC3073608.
  26. Loewen CA, Feany MB. The unfolded protein response protects from tau neurotoxicity in vivo. PLoS One. 2010 Sep 29; 5(9). PMID: 20927324; PMCID: PMC2947516.
  27. Pienaar IS, Götz J, Feany MB. Parkinson's disease: insights from non-traditional model organisms. Prog Neurobiol. 2010 Dec; 92(4):558-71. PMID: 20851733.
    View in: PubMed
  28. Khurana V, Elson-Schwab I, Fulga TA, Sharp KA, Loewen CA, Mulkearns E, Tyynelä J, Scherzer CR, Feany MB. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 2010 Jul 15; 6(7):e1001026. PMID: 20664788; PMCID: PMC2904797.
  29. Feany MB. ASIP Outstanding Investigator Award Lecture. New approaches to the pathology and genetics of neurodegeneration. Am J Pathol. 2010 May; 176(5):2058-66. PMID: 20363919; PMCID: PMC2861071.
  30. Chen L, Periquet M, Wang X, Negro A, McLean PJ, Hyman BT, Feany MB. Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest. 2009 Nov; 119(11):3257-65. PMID: 19855133.
    View in: PubMed
  31. McFarland NR, Fan Z, Xu K, Schwarzschild MA, Feany MB, Hyman BT, McLean PJ. Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. J Neuropathol Exp Neurol. 2009 May; 68(5):515-24. PMID: 19525899; PMCID: PMC2753269.
  32. Zhang S, Feany MB, Saraswati S, Littleton JT, Perrimon N. Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model. Dis Model Mech. 2009 May-Jun; 2(5-6):247-66. PMID: 19380309; PMCID: PMC2675792.
  33. Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, Boston H, Saftig P, Woulfe J, Feany MB, Myllykangas L, Schlossmacher MG, Tyynelä J. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain. 2009 Feb 09; 2:5. PMID: 19203374; PMCID: PMC2644690.
  34. Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, Rutkowski DT, Kaufman RJ, Ruse CI, Yates JR, Perrin S, Feany MB, Horwich AL. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci U S A. 2009 Feb 03; 106(5):1392-7. PMID: 19171884; PMCID: PMC2631083.
  35. Spires-Jones TL, de Calignon A, Matsui T, Zehr C, Pitstick R, Wu HY, Osetek JD, Jones PB, Bacskai BJ, Feany MB, Carlson GA, Ashe KH, Lewis J, Hyman BT. In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J Neurosci. 2008 Jan 23; 28(4):862-7. PMID: 18216194.
    View in: PubMed
  36. Steinhilb ML, Dias-Santagata D, Fulga TA, Felch DL, Feany MB. Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol Biol Cell. 2007 Dec; 18(12):5060-8. PMID: 17928404; PMCID: PMC2096612.
  37. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science. 2007 Jul 27; 317(5837):516-9. PMID: 17588900.
    View in: PubMed
  38. Dufty BM, Warner LR, Hou ST, Jiang SX, Gomez-Isla T, Leenhouts KM, Oxford JT, Feany MB, Masliah E, Rohn TT. Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation. Am J Pathol. 2007 May; 170(5):1725-38. PMID: 17456777; PMCID: PMC1854966.
  39. Steinhilb ML, Dias-Santagata D, Mulkearns EE, Shulman JM, Biernat J, Mandelkow EM, Feany MB. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J Neurosci Res. 2007 May 01; 85(6):1271-8. PMID: 17335084.
    View in: PubMed
  40. Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB. Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J Neurosci. 2007 Mar 21; 27(12):3338-46. PMID: 17376994.
    View in: PubMed
  41. Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, Feany MB. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol. 2007 Feb; 9(2):139-48. PMID: 17187063.
    View in: PubMed
  42. Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest. 2007 Jan; 117(1):236-45. PMID: 17173140; PMCID: PMC1697799.
  43. Gavin BA, Dolph MJ, Deleault NR, Geoghegan JC, Khurana V, Feany MB, Dolph PJ, Supattapone S. Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Sträussler-Scheinker syndrome. J Neurosci. 2006 Nov 29; 26(48):12408-14. PMID: 17135402.
    View in: PubMed
  44. Khurana V, Feany MB. Connecting cell-cycle activation to neurodegeneration in Drosophila. Biochim Biophys Acta. 2007 Apr; 1772(4):446-56. PMID: 17141486; PMCID: PMC2562667.
  45. Kontopoulos E, Parvin JD, Feany MB. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet. 2006 Oct 15; 15(20):3012-23. PMID: 16959795.
    View in: PubMed
  46. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol. 2006 Feb 07; 16(3):230-41. PMID: 16461276.
    View in: PubMed
  47. Orso G, Martinuzzi A, Rossetto MG, Sartori E, Feany M, Daga A. Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine. J Clin Invest. 2005 Nov; 115(11):3026-34. PMID: 16276413; PMCID: PMC1265857.
  48. Khurana V, Fulga TA, Feany MB. Senseless makes sense for spinocerebellar ataxia-1. Nat Neurosci. 2005 Nov; 8(11):1422-4. PMID: 16251977.
    View in: PubMed
  49. Myllykangas L, Tyynelä J, Page-McCaw A, Rubin GM, Haltia MJ, Feany MB. Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses. Neurobiol Dis. 2005 Jun-Jul; 19(1-2):194-9. PMID: 15837574.
    View in: PubMed
  50. Chen L, Feany MB. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci. 2005 May; 8(5):657-63. PMID: 15834418.
    View in: PubMed
  51. Colodner KJ, Montana RA, Anthony DC, Folkerth RD, De Girolami U, Feany MB. Proliferative potential of human astrocytes. J Neuropathol Exp Neurol. 2005 Feb; 64(2):163-9. PMID: 15751231.
    View in: PubMed
  52. Feany MB. New genetic insights into Parkinson's disease. N Engl J Med. 2004 Nov 04; 351(19):1937-40. PMID: 15525720.
    View in: PubMed
  53. Ghosh S, Feany MB. Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases. Hum Mol Genet. 2004 Sep 15; 13(18):2011-8. PMID: 15254017.
    View in: PubMed
  54. Scherzer CR, Feany MB. Yeast genetics targets lipids in Parkinson's disease. Trends Genet. 2004 Jul; 20(7):273-7. PMID: 15219388.
    View in: PubMed
  55. Shulman JM, Feany MB. Genetic modifiers of tauopathy in Drosophila. Genetics. 2003 Nov; 165(3):1233-42. PMID: 14668378; PMCID: PMC1462852.
  56. Feany MB, La Spada AR. Polyglutamines stop traffic: axonal transport as a common target in neurodegenerative diseases. Neuron. 2003 Sep 25; 40(1):1-2. PMID: 14527425.
    View in: PubMed
  57. Scherzer CR, Jensen RV, Gullans SR, Feany MB. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease. Hum Mol Genet. 2003 Oct 01; 12(19):2457-66. PMID: 12915459.
    View in: PubMed
  58. Shulman JM, Shulman LM, Weiner WJ, Feany MB. From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease. Curr Opin Neurol. 2003 Aug; 16(4):443-9. PMID: 12869801.
    View in: PubMed
  59. Deleault NR, Dolph PJ, Feany MB, Cook ME, Nishina K, Harris DA, Supattapone S. Post-transcriptional suppression of pathogenic prion protein expression in Drosophila neurons. J Neurochem. 2003 Jun; 85(6):1614-23. PMID: 12787080.
    View in: PubMed
  60. Feany MB, Pallanck LJ. Parkin: a multipurpose neuroprotective agent? Neuron. 2003 Apr 10; 38(1):13-6. PMID: 12691660.
    View in: PubMed
  61. Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003 Apr 01; 100(7):4078-83. PMID: 12642658; PMCID: PMC153051.
  62. Muqit MM, Feany MB. Modelling neurodegenerative diseases in Drosophila: a fruitful approach? Nat Rev Neurosci. 2002 Mar; 3(3):237-43. PMID: 11994755.
    View in: PubMed
  63. Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science. 2001 Jul 27; 293(5530):711-4. PMID: 11408621.
    View in: PubMed
  64. Feany MB, Anthony DC, Frosch MP, Zane W, De Girolami U. August 2000: Two cases with necrosis and hemorrhage in the putamen and white matter. Brain Pathol. 2001 Jan; 11(1):121-2, 125. PMID: 11145199.
    View in: PubMed
  65. Feany MB. Studying human neurodegenerative diseases in flies and worms. J Neuropathol Exp Neurol. 2000 Oct; 59(10):847-56. PMID: 11079774.
    View in: PubMed
  66. Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature. 2000 Mar 23; 404(6776):394-8. PMID: 10746727.
    View in: PubMed
  67. Chapman P, Stieg PE, Magge S, Barnes P, Feany M. Spinal lipoma controversy. Neurosurgery. 1999 Jan; 44(1):186-92; discussion 192-3. PMID: 9894980.
    View in: PubMed
  68. Feany MB, Anthony DC, Fletcher CD. Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge. Histopathology. 1998 May; 32(5):405-10. PMID: 9639114.
    View in: PubMed
  69. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol. 1996 Aug; 40(2):139-48. PMID: 8773594.
    View in: PubMed
  70. Feany MB. Neuropeptide modulation of learning and memory processes. Rev Neurosci. 1996 Apr-Jun; 7(2):151-64. PMID: 8819207.
    View in: PubMed
  71. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol. 1996 Jan; 55(1):53-67. PMID: 8558172.
    View in: PubMed
  72. Dickson DW, Feany MB, Yen SH, Mattiace LA, Davies P. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration. J Neural Transm Suppl. 1996; 47:31-46. PMID: 8841955.
    View in: PubMed
  73. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol. 1995 Jun; 146(6):1388-96. PMID: 7778678; PMCID: PMC1870913.
  74. Feany MB, Quinn WG. A neuropeptide gene defined by the Drosophila memory mutant amnesiac. Science. 1995 May 12; 268(5212):869-73. PMID: 7754370.
    View in: PubMed
  75. Feany MB, Ksiezak-Reding H, Liu WK, Vincent I, Yen SH, Dickson DW. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol. 1995; 90(1):37-43. PMID: 7572077.
    View in: PubMed
  76. Feany MB, Yee AG, Delvy ML, Buckley KM. The synaptic vesicle proteins SV2, synaptotagmin and synaptophysin are sorted to separate cellular compartments in CHO fibroblasts. J Cell Biol. 1993 Nov; 123(3):575-84. PMID: 7901222; PMCID: PMC2200136.
  77. Feany MB, Buckley KM. The synaptic vesicle protein synaptotagmin promotes formation of filopodia in fibroblasts. Nature. 1993 Aug 05; 364(6437):537-40. PMID: 8166886.
    View in: PubMed
  78. Feany MB, Lee S, Edwards RH, Buckley KM. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell. 1992 Sep 04; 70(5):861-7. PMID: 1355409.
    View in: PubMed
  79. Feany MB. Rescue of the learning defect in dunce, a Drosophila learning mutant, by an allele of rutabaga, a second learning mutant. Proc Natl Acad Sci U S A. 1990 Apr; 87(7):2795-9. PMID: 2157213; PMCID: PMC53777.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at For faculty personal and demographic information, contact HMS Office for Faculty Affairs at
Feany's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
Co-Authors Expand Description
Similar People Expand Description
Same Department Expand Description
Physical Neighbors Expand Description